Sunday, June 14, 2020

CDSCO reviewing Remdesivir applications on priority basis

CDSCO reviewing Remdesivir applications on priority basis "Being an injectable formulation, testing for assay, identity, impurities, bacterial endotoxin test and sterility become very critical for patient safety and this data need to be provided by the companies," it added.

from Moneycontrol Business News https://ift.tt/2XZMjq8

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...